| Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes SA Brown, BP Kovatchev, D Raghinaru, JW Lum, BA Buckingham, ... New England Journal of Medicine 381 (18), 1707-1717, 2019 | 928 | 2019 |
| Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial RE Pratley, LG Kanapka, MR Rickels, A Ahmann, G Aleppo, R Beck, ... Jama 323 (23), 2397-2406, 2020 | 277 | 2020 |
| Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes SA Brown, GP Forlenza, BW Bode, JE Pinsker, CJ Levy, AB Criego, ... Diabetes Care 44 (7), 1630-1640, 2021 | 198 | 2021 |
| A prospective multicenter evaluation of the accuracy of a novel implanted continuous glucose sensor: PRECISE II MP Christiansen, LJ Klaff, R Brazg, AR Chang, CJ Levy, D Lam, ... Diabetes technology & therapeutics 20 (3), 197-206, 2018 | 150 | 2018 |
| Closed-loop control without meal announcement in type 1 diabetes FM Cameron, TT Ly, BA Buckingham, DM Maahs, GP Forlenza, CJ Levy, ... Diabetes technology & therapeutics 19 (9), 527-532, 2017 | 106 | 2017 |
| Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the international diabetes closed-loop trial E Isganaitis, D Raghinaru, L Ambler-Osborn, JE Pinsker, BA Buckingham, ... Diabetes Technology & Therapeutics 23 (5), 342-349, 2021 | 102 | 2021 |
| Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM CJ Levy, BT Kinsley, M Bajaj, DC Simonson Diabetes care 21 (8), 1330-1338, 1998 | 99 | 1998 |
| Wireless Innovation for Seniors With Diabetes Mellitus (WISDM) Study Group. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a … RE Pratley, LG Kanapka, MR Rickels, A Ahmann, G Aleppo, R Beck, ... Jama 323 (23), 2397-2406, 2020 | 92 | 2020 |
| Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. BT Kinsley, K Weinger, M Bajaj, CJ Levy, DC Simonson, M Quigley, ... Diabetes Care 22 (7), 1022-1028, 1999 | 88 | 1999 |
| Fully closed-loop multiple model probabilistic predictive controller artificial pancreas performance in adolescents and adults in a supervised hotel setting GP Forlenza, FM Cameron, TT Ly, D Lam, DP Howsmon, N Baysal, ... Diabetes technology & therapeutics 20 (5), 335-343, 2018 | 81 | 2018 |
| COVID-19 hospitalization in adults with type 1 diabetes: results from the T1D exchange multicenter surveillance study G O’Malley, O Ebekozien, M Desimone, CT Pinnaro, A Roberts, S Polsky, ... The Journal of Clinical Endocrinology & Metabolism 106 (2), e936-e942, 2021 | 74 | 2021 |
| The perception of safe driving ability during hypoglycemia in patients with type 1 diabetes mellitus K Weinger, BT Kinsley, CJ Levy, M Bajaj, DC Simonson, DJ Cox, ... The American journal of medicine 107 (3), 246-253, 1999 | 71 | 1999 |
| Performance of the Dexcom G6 continuous glucose monitoring system in pregnant women with diabetes K Castorino, S Polsky, G O'Malley, C Levister, K Nelson, C Farfan, ... Diabetes technology & therapeutics 22 (12), 943-947, 2020 | 65 | 2020 |
| Age and hospitalization risk in people with type 1 diabetes and COVID-19: data from the T1D Exchange Surveillance Study C Demeterco-Berggren, O Ebekozien, S Rompicherla, L Jacobsen, ... The Journal of Clinical Endocrinology & Metabolism 107 (2), 410-418, 2022 | 58 | 2022 |
| First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes GP Forlenza, BA Buckingham, SA Brown, BW Bode, CJ Levy, AB Criego, ... Diabetes technology & therapeutics 23 (6), 410-424, 2021 | 58 | 2021 |
| Randomized controlled trial of mobile closed-loop control B Kovatchev, SM Anderson, D Raghinaru, YC Kudva, LM Laffel, C Levy, ... Diabetes Care 43 (3), 607-615, 2020 | 57 | 2020 |
| Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes KM Miller, LG Kanapka, MR Rickels, AJ Ahmann, G Aleppo, L Ang, ... Diabetes technology & therapeutics 24 (6), 424-434, 2022 | 52 | 2022 |
| Patient-reported outcomes in a randomized trial of closed-loop control: the pivotal international diabetes closed-loop trial YC Kudva, LM Laffel, SA Brown, D Raghinaru, JE Pinsker, L Ekhlaspour, ... Diabetes Technology & Therapeutics 23 (10), 673-683, 2021 | 50 | 2021 |
| Glycemic outcomes of use of CLC versus PLGS in type 1 diabetes: a randomized controlled trial SA Brown, RW Beck, D Raghinaru, BA Buckingham, LM Laffel, ... Diabetes Care 43 (8), 1822-1828, 2020 | 46 | 2020 |
| Real-world evidence supporting tandem control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations GP Forlenza, AL Carlson, RJ Galindo, DF Kruger, CJ Levy, JB McGill, ... Diabetes technology & therapeutics 24 (11), 814-823, 2022 | 45 | 2022 |
